Guideline on shared facilities coming into effect 01 June 2015

For medicinal products introduced for the first time into shared manufacturing facilities: December 1st 2015.

 

For medicinal products already produced in shared manufacturing facilities the guidance will take effect, or existing arrangements should be scientifically justified, within:

  • June 1st 2016 for manufacturers of products for human use

including those who manufacture human and veterinary medicines using shared manufacturing facilities.

  • June 1st 2017 for manufacturers solely producing products for veterinary use.

Latest news

CPhI 2017

Socosur is exhibiting on INDIS associates booth 80F02. During the exhibition an Azierta...(...)

AZIERTA exclusive agency for INDIA

The Azierta Socosur agreement on PDE, OEL, ICHQ and other toxicology services have been extended to...(...)

New Service - ICH Q3D

New service as part of Azierta cooperation: ICH Q3D – Elemental impurities Implementation of r...(...)

Exclusive agency for Azierta PDE monographs

Azierta and Socosur just entered an exclusive agency agreement for PDE monographs elaborated by...(...)

Stay in touch

Contact us